Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

The efficacy of the American College of Surgeons Surgical Risk Calculator in the prediction of postoperative complications in oncogeriatric patients after curative surgery for abdominal tumors.

Auteurs : El Asmar A, Hafez K, Fauconnier P, Moreau M, Dal Lago L, Pepersack T, Donckier V, Liberale G
Jaar : 2022
Journal : J Surg Oncol
Volume : 126
Pagina's : 1359-1366

Code of practice needed for samples donated by trial participants.

Auteurs : Coleman R, Chan A, Barrios C, Cameron D, Costa L, Dowsett M, Harrison D, Howell A, Lacombe D, MacKenzie M, Martin M, McIntosh S, Morgan A, Piccart-Gebhart M, Spanic T
Jaar : 2022
Journal : Lancet Oncol
Volume : 23
Pagina's : e89-e90

Isolated oesophageal Crohn's disease mimicking oesophageal carcinoma treated by Merendino procedure.

Auteurs : Al Zoghby S, Bohlok A, Moschopoulos C, Toussaint E, Verset L, Demetter P, El Nakadi I
Jaar : 2022
Journal : Ann R Coll Surg Engl
Volume : 104
Pagina's : e17-e20

Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.

Auteurs : Martins-Branco D, Nader-Marta G, Tecic Vuger A, Debien V, Ameye L, Brandão M, Punie K, Loizidou A, Willard-Gallo K, Spilleboudt C, Awada A, Piccart M, de Azambuja E
Jaar : 2022
Journal : J Cancer Res Clin Oncol
Pagina's : 1-6

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.

Auteurs : Agostinetto E, Losurdo A, Nader-Marta G, Santoro A, Punie K, Barroso R, Popovic L, Solinas C, Kok M, de Azambuja E, Lambertini M
Jaar : 2022
Journal : Expert Opin Investig Drugs
Volume : 31
Pagina's : 567-591

De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.

Auteurs : Conte B, Soldato D, Razeti MG, Fregatti P, de Azambuja E, Schettini F, Prat A, Del Mastro L, Lambertini M
Jaar : 2022
Journal : Clin Breast Cancer
Volume : 22
Pagina's : 78-87

HER2-Low Breast Cancer: Where Are We?

Auteurs : Molinelli C, Jacobs F, Marchiò C, Pitto F, Cosso M, Spinaci S, de Azambuja E, Schettini F, Agostinetto E, Lambertini M
Jaar : 2022
Journal : Breast Care (Basel)
Volume : 17
Pagina's : 533-545

Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.

Auteurs : Cau R, Solinas C, De Silva P, Lambertini M, Agostinetto E, Scartozzi M, Montisci R, Pontone G, Porcu M, Saba L
Jaar : 2022
Journal : Int J Cancer
Volume : 151
Pagina's : 1860-1873

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.

Auteurs : Koessler T, Alsina M, Arnold D, Ben-Aharon I, Collienne M, Lutz MP, Neuzillet C, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100392

(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Auteurs : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Jaar : 2022
Journal : J Nucl Med
Volume : 63
Pagina's : 1191-1198

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.

Auteurs : Geukens T, Brandão M, Laenen A, Collignon J, Van Marcke C, Louviaux I, Demey W, Van Wambeke S, Schrijvers D, Lecomte S, Mebis J, Rutten A, Fontaine C, Lybaert W, Aspeslagh S, Goeminne JC, Van den Bulck H, Seront E, De Backer L, De Roock W, Ignatiadis M, Prenen H, Van Beckhoven D, Heijlen M, Verheezen J, Rottey S, Punie K, de Azambuja E
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100610

ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.

Auteurs : Agostinetto E, Nader-Marta G, Paesmans M, Ameye L, Veys I, Buisseret L, Neven P, Taylor D, Fontaine C, Duhoux FP, Canon JL, Denys H, Coussy F, Chakiba C, Ribeiro JM, Piccart M, Desmedt C, Ignatiadis M, Aftimos P
Jaar : 2022
Journal : Future Oncol
Volume : 18
Pagina's : 2383-2392

Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients.

Auteurs : Penning Y, El Asmar A, Moreau M, Raspé J, Dal Lago L, Pepersack T, Donckier V, Liberale G
Jaar : 2022
Journal : PLoS One
Volume : 17
Pagina's : e0264790

Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Auteurs : Robijns J, Nair RG, Lodewijckx J, Arany P, Barasch A, Bjordal JM, Bossi P, Chilles A, Corby PM, Epstein JB, Elad S, Fekrazad R, Fregnani ER, Genot MT, Ibarra AMC, Hamblin MR, Heiskanen V, Hu K, Klastersky J, Lalla R, Latifian S, Maiya A, Mebis J, Migliorati CA, Milstein DMJ, Murphy B, Raber-Durlacher JE, Roseboom HJ, Sonis S, Treister N, Zadik Y, Bensadoun RJ
Jaar : 2022
Journal : Front Oncol
Volume : 12
Pagina's : 927685

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.

Auteurs : Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, Langouo Fontsa M
Jaar : 2022
Journal : Diagnostics (Basel)
Volume : 12

Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets.

Auteurs : Zambelli A, Sgarra R, De Sanctis R, Agostinetto E, Santoro A, Manfioletti G
Jaar : 2022
Journal : Expert Opin Ther Targets
Volume : 26
Pagina's : 557-573

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.

Auteurs : Dal Lago L, Uwimana AL, Coens C, Vuylsteke P, Curigliano G, Brouwers B, Jagiello-Gruszfeld A, Altintas S, Tryfonidis K, Poncet C, Bottomley A, Sousa B, Brain E, Wildiers H
Jaar : 2022
Journal : J Geriatr Oncol
Volume : 13
Pagina's : 582-593

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.

Auteurs : Chang CA, Jen J, Jiang S, Sayad A, Mer AS, Brown KR, Nixon AML, Dhabaria A, Tang KH, Venet D, Sotiriou C, Deng J, Wong KK, Adams S, Meyn P, Heguy A, Skok JA, Tsirigos A, Ueberheide B, Moffat J, Singh A, Haibe-Kains B, Khodadadi-Jamayran A, Neel BG
Jaar : 2022
Journal : Cancer Discov
Volume : 12
Pagina's : 1022-1045

Delivering precision oncology to patients with cancer.

Auteurs : Mateo J, Steuten L, Aftimos P, André F, Davies M, Garralda E, Geissler J, Husereau D, Martinez-Lopez I, Normanno N, Reis-Filho JS, Stefani S, Thomas DM, Westphalen CB, Voest E
Jaar : 2022
Journal : Nat Med
Volume : 28
Pagina's : 658-665

Results of a single-arm pilot study of (32)P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy.

Auteurs : Ross PJ, Wasan HS, Croagh D, Nikfarjam M, Nguyen N, Aghmesheh M, Nagrial AM, Bartholomeusz D, Hendlisz A, Ajithkumar T, Iwuji C, Wilson NE, Turner DM, James DC, Young E, Harris MT
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100356